Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $9
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and lowers the price target from $9.5 to $9.
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and lowers the price target from $9.5 to $9.